Dec 31 (Reuters) - HLS Therapeutics Inc HLS.TO :
* HLS THERAPEUTICS ANNOUNCES HEALTH CANADA APPROVAL FOR VASCEPA® TO REDUCE THE RISK OF CARDIOVASCULAR EVENTS
* HLS THERAPEUTICS INC - COMMERCIAL LAUNCH FOR VASCEPA IN CANADA EXPECTED TO TAKE PLACE IN MID-FEBRUARY 2020 TIMEFRAME